HanAll Biopharma, Applied the Clinical Trial Phase 1 for New..
HanAll Biopharma(CO-CEO Seong-uk Kim and
Seung-kook Park) is generously donating essential supplies to facilities that
cater to disabled individuals and senior citizens across the country, aiming to
spread love and support within local communities.
Since expanding its interest to cosmetics
industry in 2013, HanAll Biopharma has been regularly contributing moisturizing
products to welfare facilities. This donation includes HanAll\'s own moisturizer
called \'ATOHONG,\' as well as \'Linola Shampoo\' and \'Linola Fett N Olbad,\' worth
17 million KRW.
The Linola products from Dr. Kurt Wolff are
highly regarded for their exceptional moisturizing effects, free from steroids,
colors, or preservatives, making them safe for children and the elderly.
"Linola Shampoo" is a gentle cleanser specially formulated for sensitive
scalps, suitable for daily use by children and the elderly. "Linola Fett N
Olbad" is an oil-based product used during baths or showers, providing
both moisture and nourishment to the skin while cleansing. After showering,
there is no need to apply additional moisturizers, making it convenient for
volunteer service workers.
Dr. Kurt Wolff\'s Linola products have been
distributed to various welfare facilities nationwide, including ‘HanAll Life’,
a social welfare organization for senior citizens in Goseong, Gyeongsangnam-do;
"Dain Silver Home" in Haeundae, Busan; "Shinmangae Welfare
Foundation" for disabled individuals in Seocho-gu, Seoul; "Hanwool
Community for Disabled" in Yongin, Gyeonggi-do; and "Seonmyeong Care
Center" in Dong-gu, Daegu.
“During winter, the combination of cold
wind and low temperatures tends to exacerbate dry skin, causing discomfort and
itchiness. In such circumstances, the exceptional moisturizing properties of
Linola products prove to be highly beneficial for individuals experiencing
these conditions. HanAll Biopharma is dedicated to going beyond the provision
of goods and aspires to become a beacon of hope within local communities, “said
an official from HanAll Biopharma.
HanAll engages in annual donations
amounting to 0.2% of salaries from both executives and employees. Additionally,
the company actively participates in a wide range of social contribution
initiatives, including providing free food services, offering medical aid,
engaging in domestic and international medical volunteer services, promoting
organ donation campaigns, and organizing blood donation events.